Terms: = Kidney tumors AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Prognosis
20 results:
1. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
[TBL] [Abstract] [Full Text] [Related]
2. Sesamin suppresses NSCLC cell proliferation and induces apoptosis via Akt/p53 pathway.
Chen Y; Li H; Zhang W; Qi W; Lu C; Huang H; Yang Z; Liu B; Zhang L
Toxicol Appl Pharmacol; 2020 Jan; 387():114848. PubMed ID: 31809756
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Biomarkers for the Prediction of Stage and prognosis of Upper Tract Urothelial Carcinoma.
Bagrodia A; Cha EK; Sfakianos JP; Zabor EC; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA; Iyer G; Scott SN; Shah R; Ostrovnaya I; Lee B; Desai NB; Ren Q; Rosenberg JE; Dalbagni G; Bajorin DF; Reuter VE; Berger MF;
J Urol; 2016 Jun; 195(6):1684-1689. PubMed ID: 26778714
[TBL] [Abstract] [Full Text] [Related]
4. A GRIA2 and PAX8-positive renal solitary fibrous tumor with NAB2-STAT6 gene fusion.
Ichiyanagi O; Ito H; Takai S; Naito S; Kato T; Nagaoka A; Yamakawa M
Diagn Pathol; 2015 Sep; 10():155. PubMed ID: 26337721
[TBL] [Abstract] [Full Text] [Related]
5. P53 and mdm2 Over-expression and Five-year Survival of kidney Cancer Patients Undergoing Radical Nephrectomy--Iranian Experience.
Abolhasani M; Salarinejad S; Asgari M
Asian Pac J Cancer Prev; 2015; 16(12):5043-7. PubMed ID: 26163638
[TBL] [Abstract] [Full Text] [Related]
6. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/hdm2 signaling pathway.
Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN
Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860
[TBL] [Abstract] [Full Text] [Related]
7. The T309G murine double minute 2 gene polymorphism is an independent prognostic factor for patients with renal cell carcinoma.
de Martino M; Taus C; Wessely IS; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
DNA Cell Biol; 2015 Feb; 34(2):107-12. PubMed ID: 25415135
[TBL] [Abstract] [Full Text] [Related]
8. Selected morphologic features influencing the prognosis of conventional renal cell carcinomas co-expressing P53 and mdm2.
Hejnold M; Dyduch G; Białas M; Demczuk S; Ryś J; Szopiński T; Chłosta P; Okoń K
Pol J Pathol; 2014 Mar; 65(1):29-33. PubMed ID: 25119006
[TBL] [Abstract] [Full Text] [Related]
9. Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on mdm2 antagonism.
Polański R; Noon AP; Blaydes J; Phillips A; Rubbi CP; Parsons K; Vlatković N; Boyd MT
Cancer Lett; 2014 Oct; 353(2):211-9. PubMed ID: 25067787
[TBL] [Abstract] [Full Text] [Related]
10. Combined p53 and mdm2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy.
Noon AP; Polański R; El-Fert AY; Kalirai H; Shawki H; Campbell F; Dodson A; Eccles RM; Lloyd BH; Sibson DR; Coupland SE; Lake SL; Parsons K; Vlatković N; Boyd MT
BJU Int; 2012 Apr; 109(8):1250-7. PubMed ID: 21756282
[TBL] [Abstract] [Full Text] [Related]
11. Amplification and expression of EGFR and ERBB2 in Wilms tumor.
Vasei M; Modjtahedi H; Ale-Booyeh O; Mosallaei A; Kajbafzadeh AM; Shahriari M; Ghaderi AA; Soleymanpour H; Kosari F; Moch H; Sauter G
Cancer Genet Cytogenet; 2009 Oct; 194(2):88-95. PubMed ID: 19781441
[TBL] [Abstract] [Full Text] [Related]
12. Simple quantification of multiplexed quantum dot staining in clinical tissue samples.
Caldwell ML; Moffitt RA; Liu J; Parry RM; Sharma Y; Wang MD
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():1907-10. PubMed ID: 19163062
[TBL] [Abstract] [Full Text] [Related]
13. mdm2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract] [Full Text] [Related]
14. Functional and gene expression analysis of the p53 signaling pathway in clear cell sarcoma of the kidney and congenital mesoblastic nephroma.
Brownlee NA; Hazen-Martin DJ; Garvin AJ; Re GG
Pediatr Dev Pathol; 2002; 5(3):257-68. PubMed ID: 12007018
[TBL] [Abstract] [Full Text] [Related]
15. Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.
Uchida T; Gao JP; Wang C; Jiang SX; Muramoto M; Satoh T; Minei S; Shimura S; Irie A; Kameya T; Baba S
Urology; 2002 Apr; 59(4):615-20. PubMed ID: 11927338
[TBL] [Abstract] [Full Text] [Related]
16. Roles of p53 and mdm2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter.
Hashimoto H; Sue Y; Saga Y; Tokumitsu M; Yachiku S
Int J Urol; 2000 Dec; 7(12):457-63. PubMed ID: 11168685
[TBL] [Abstract] [Full Text] [Related]
17. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway.
Morimitsu Y; Nakajima M; Hisaoka M; Hashimoto H
APMIS; 2000 Sep; 108(9):617-25. PubMed ID: 11110050
[TBL] [Abstract] [Full Text] [Related]
18. p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma.
Moch H; Sauter G; Gasser TC; Buchholz N; Bubendorf L; Richter J; Jiang F; Dellas A; Mihatsch MJ
Urol Res; 1997; 25 Suppl 1():S25-30. PubMed ID: 9079753
[TBL] [Abstract] [Full Text] [Related]
19. p53 mutations and MDM-2 amplification in renal cell cancers.
Imai Y; Strohmeyer TG; Fleischhacker M; Slamon DJ; Koeffler HP
Mod Pathol; 1994 Sep; 7(7):766-70. PubMed ID: 7824511
[TBL] [Abstract] [Full Text] [Related]
20. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations.
Bardeesy N; Falkoff D; Petruzzi MJ; Nowak N; Zabel B; Adam M; Aguiar MC; Grundy P; Shows T; Pelletier J
Nat Genet; 1994 May; 7(1):91-7. PubMed ID: 8075648
[TBL] [Abstract] [Full Text] [Related]